General form of registration statement for all companies including face-amount certificate companies

Stock-Based Compensation (Tables)

v3.22.4
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]    
Summary of Option Activity Under 2011 Plan and 2020 Plan  
The following is a summary of option activity under the 2011 Plan and the 2020 Plan:
 
    
Number of
Shares
    
Weighted-
Average
Exercise
Price
Per Share
    
Weighted-
Average
Remaining
Contractual
Term
(In Years)
 
Outstanding at December 31, 2019
     3,369,144      $ 1.75        7.78  
Granted
     227,300        10.00        6.98  
Exercised
     —          —          —    
Forfeited
     —          —          —    
Cancelled
     —          —          —    
    
 
 
    
 
 
    
 
 
 
Outstanding at December 31, 2020
     3,596,444        2.27        7.73  
Granted
     215,898        3.88        6.40  
Exercised
     (112,268      0.70        —    
Forfeited
     (40,708      0.38        —    
Cancelled
     —          —          —    
    
 
 
    
 
 
    
 
 
 
Outstanding at December 31, 2021
     3,659,366        2.43        6.99  
    
 
 
    
 
 
    
 
 
 
Exercisable at December 31, 2021
     3,378,761        2.13        7.05  
    
 
 
    
 
 
    
 
 
 
Schedule of Estimated Assumptions of Weighted-Average Fair Values of Options Granted  
The weighted-average fair values of options granted in the years ended December 31, 2021 and 2020 were $2.24 and $6.45, per share, respectively, and were calculated using the following estimated assumptions:
 
    
Year ended December 31,
 
    
2021
   
2020
 
Weighted-average risk-free interest rate
  
 
0.59
 
 
0.32
Expected dividend yield
  
 
0.00
 
 
0.00
Expected volatility
  
 
82.22
 
 
87.63
Expected terms
  
 
3.97 years
 
 
 
4.44 years
 
Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees
The following table summarizes the stock-based compensation expense for stock options granted to employees and
non-employees:
 
    
Nine Months Ended
September 30,
 
    
2022
    
2021
 
Research and development
   $ 98,722      $ 592,966  
Selling, general and administrative
     259,062        673,060  
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 357,784      $ 1,266,026  
    
 
 
    
 
 
 
The following table summarizes the stock-based compensation expense for stock options granted to employees and
non-employees:
 
    
Year ended December 31,
 
    
2021
    
2020
 
Research and development
  
$
665,834
 
  
$
261,492
 
Selling, general and administrative
  
 
866,042
 
  
 
312,203
 
    
 
 
    
 
 
 
Total stock-based compensation expense
  
$
1,531,876
 
  
$
573,695